{"id":8206,"date":"2020-09-10T04:20:26","date_gmt":"2020-09-10T09:20:26","guid":{"rendered":"https:\/\/cornflowerblue-rail-980953.hostingersite.com\/?p=8206"},"modified":"2020-09-10T04:20:26","modified_gmt":"2020-09-10T09:20:26","slug":"whats-new-in-breast-imaging-turkish-september-2020","status":"publish","type":"post","link":"https:\/\/staging-hub.acoredu.com\/tr\/whats-new-in-breast-imaging-turkish-september-2020\/","title":{"rendered":"What&#8217;s new in Breast Imaging (Turkish) &#8211; September 2020"},"content":{"rendered":"<h5><span style=\"color: #3366ff;\"><strong>Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation<\/strong><\/span><\/h5>\n<p>Mori, N., Sheth, D., &amp; Abe, H. (2020).<\/p>\n<p>American Journal of Roentgenology, 215(2), 511-518.<\/p>\n<p>Link: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32452698\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32452698\/<\/a><\/p>\n<h5><strong>Kitlesel Olmayan Kontrastlanma Paternine Sahip \u00a0Meme Lezyonlar\u0131: Diagnostik Performans a\u00e7\u0131s\u0131ndan Ultrah\u0131zl\u0131 ve Standart Dinamik Kontrastl\u0131\u00a0 MRI\u2019da Kinetik De\u011ferlendirmenin, Morfolojik De\u011ferlendirmeyle Kar\u015f\u0131la\u015ft\u0131r\u0131lmas\u0131<\/strong><\/h5>\n<p>Bu \u00e7al\u0131\u015fmada yazarlar, ultra h\u0131zl\u0131 ve standart dinamik kontrastl\u0131 MRG&#8217;den (DCE-MRI) al\u0131nan kinetik parametrelerin, lezyon morfolojisine k\u0131yasla malign kitlesel olmayan kontrastlanmadan (NME) ay\u0131rt edip edemeyece\u011fini belirlemeye \u00e7al\u0131\u015ft\u0131lar. NME&#8217;li 77 hastaya (54 k\u00f6t\u00fc huylu ve 23 iyi huylu) meme MRG \u00e7ekildi. Deneyimli meme radyologlar\u0131 NME morfolojisini de\u011ferlendirdi ve her lezyona %0-100 aras\u0131nda bir malignite olas\u0131l\u0131\u011f\u0131 skoru verdi. Kinetik parametreler hem ultra h\u0131zl\u0131 hem de standart DCE-MRI i\u00e7in hesapland\u0131 ve benign ve malign lezyonlar i\u00e7in kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131. Benign lezyonlarla kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda, malign lezyonlar daha y\u00fcksek morfolojik malignite olas\u0131l\u0131k skorlar\u0131na sahipti (p &lt;0.0001). K\u00f6t\u00fc huylu lezyonlar, \u015fu parametreler i\u00e7in benign lezyonlara k\u0131yasla istatistiksel olarak anlaml\u0131 \u015fekilde daha y\u00fcksek de\u011ferlere sahipti: sinyal art\u0131\u015f h\u0131z\u0131, sinyal yo\u011funlu\u011funun \u00fcst s\u0131n\u0131r\u0131, AUC30 (0 ila 30 saniye aras\u0131nda kinetik e\u011frinin entegrasyonu) ve ultra h\u0131zl\u0131 DCE- MRG&#8217;deki kinetik e\u011frinin ba\u015flang\u0131\u00e7 \u200b\u200be\u011fimi. Ek olarak, standart DCE-MRI&#8217;da sinyal geli\u015ftirme oran\u0131 (SER) ve ba\u015flang\u0131\u00e7 \u200b\u200bg\u00fc\u00e7lendirme oran\u0131, malign lezyonlar i\u00e7in \u00f6nemli \u00f6l\u00e7\u00fcde daha y\u00fcksekti. Bununla birlikte, morfolojik skor, EAA 30 veya SER aras\u0131nda istatistiksel olarak anlaml\u0131 bir fark yoktu. Yazarlar, iyi huylu ve k\u00f6t\u00fc huylu NME aras\u0131nda ayr\u0131m yaparken, DCE-MRI \u00fczerindeki kinetik parametrelerin morfolojik karakterizasyon kadar etkili oldu\u011fu sonucuna varm\u0131\u015flard\u0131r.<\/p>\n<p>&nbsp;<\/p>\n<h5><span style=\"color: #3366ff;\"><strong>Left\u2013right breast asymmetry and risk of screen-detected and interval cancers in a large population-based screening population<\/strong><\/span><\/h5>\n<p>Hudson, S. M., Wilkinson, L. S., Stavola, B. L., &amp; Dos-Santos-Silva, I. (2020).<\/p>\n<p>The British Journal of Radiology, 93(1112), 20200154.<\/p>\n<p>Link: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32525693\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32525693\/<\/a><\/p>\n<h5><strong>Sol-sa\u011f meme asimetrisi ve geni\u015f bir pop\u00fclasyon tabanl\u0131 taramayla ve intervalde \u00a0tespit edilen kanser riski.<\/strong><\/h5>\n<p>Bu \u00e7al\u0131\u015fmada yazarlar, \u00e7e\u015fitli zaman aral\u0131klar\u0131nda mamografik asimetri ile meme kanseri te\u015fhisi aras\u0131ndaki ili\u015fkiyi ara\u015ft\u0131rmaya \u00e7al\u0131\u015ft\u0131lar. Yakla\u015f\u0131k 80.000 mamografik g\u00f6r\u00fcnt\u00fcden otomatik hesaplamalar, Birle\u015fik Krall\u0131k&#8217;taki bir meme kanseri tarama program\u0131n\u0131n etnik a\u00e7\u0131dan \u00e7ok \u00e7e\u015fitli b\u00fcy\u00fck bir pop\u00fclasyonunda asimetrik yo\u011fun hacmi (DV) ve meme hacmini (BV) belirlemek i\u00e7in kullan\u0131ld\u0131. Asimetri \u00f6l\u00e7\u00fcmleri ile e\u015fzamanl\u0131 (ayn\u0131 g\u00fcn) bir ekranda meme kanseri tespit olas\u0131l\u0131klar\u0131 aras\u0131ndaki ili\u015fki, lojistik regresyon modelleri kullan\u0131larak hesapland\u0131. Ek olarak, i\u00e7 i\u00e7e ge\u00e7mi\u015f vaka-kontrol \u00e7al\u0131\u015fmalar\u0131, meme asimetrileri ile sonraki taramalarda veya taramalar aras\u0131nda (aral\u0131kl\u0131 te\u015fhis) meme kanseri tespiti aras\u0131ndaki ili\u015fkiyi belirlemi\u015ftir. Yazarlar, e\u015fzamanl\u0131 meme kanseri ve asimetrik DV (ancak BV de\u011fil) olas\u0131l\u0131\u011f\u0131 aras\u0131nda, ilk taramalar i\u00e7in daha g\u00fc\u00e7l\u00fc olmak \u00fczere pozitif bir ili\u015fki ke\u015ffettiler. Aral\u0131kl\u0131 kanser tespiti olas\u0131l\u0131\u011f\u0131 ile hem BV hem de DV asimetrisi aras\u0131nda pozitif bir ili\u015fki vard\u0131. Ne BV ne de DV asimetrisi, sonraki ekranlarda artan kanser saptama olas\u0131l\u0131\u011f\u0131 ile ili\u015fkilendirilmedi. Yazarlar, e\u015fzamanl\u0131 veya aral\u0131kl\u0131 meme kanseri te\u015fhisi riskinin artm\u0131\u015f DV asimetrisi ile ili\u015fkili oldu\u011fu sonucuna varm\u0131\u015flard\u0131r. Benzer \u015fekilde, aral\u0131kl\u0131 meme kanseri te\u015fhisi, BV asimetrisi ile pozitif olarak ili\u015fkilidir<\/p>\n<p>&nbsp;<\/p>\n<h5><strong><span style=\"color: #3366ff;\">Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI.<\/span><\/strong><\/h5>\n<p>Pan, J., Tong, W., Luo, J., Liang, J., Pan, F., Zheng, Y., &amp; Xie, X. (2020).<\/p>\n<p>The British Journal of Radiology, 93(1112), 20200195.<\/p>\n<p>Link: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32463295\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32463295\/<\/a><\/p>\n<h5><strong>Kontrastl\u0131 ultrason (CEUS) kalsifiye \u00a0meme lezyonlar\u0131n\u0131n te\u015fhisinde daha iyi bir rol oynar m\u0131? MRI ile kar\u015f\u0131la\u015ft\u0131rma.<\/strong><\/h5>\n<p>Bu \u00e7al\u0131\u015fmada yazarlar, kalsifikasyonlu meme lezyonlar\u0131n\u0131n te\u015fhisinde kontrastl\u0131 ultrason BI-RADS (CEUS-BI-RADS) ile MRI-BI-RADS&#8217;nin tan\u0131sal etkinli\u011fini kar\u015f\u0131la\u015ft\u0131rmaya \u00e7al\u0131\u015ft\u0131lar. \u00c7al\u0131\u015fmaya 51 hasta dahil edildi ve ultrasonda hiperekoik kalsifiye alan izlenen 52 meme lezyonu saptand\u0131. Her lezyona geleneksel ultrasonda bir BI-RADS 3-5 skoru verildi. Hastalara daha sonra CEUS ve MRG yap\u0131ld\u0131 ve ek BI-RADS s\u0131n\u0131fland\u0131rmalar\u0131 yap\u0131ld\u0131. \u00dc\u00e7 modalite aras\u0131nda yazarlar, duyarl\u0131l\u0131k veya ROC alt\u0131nda alan a\u00e7\u0131s\u0131ndan istatistiksel olarak anlaml\u0131 bir fark bulamad\u0131lar (p&gt; 0.05). Bununla birlikte, yazarlar, CEUS-BI-RADS&#8217;nin \u00f6zg\u00fcll\u00fc\u011f\u00fcn\u00fcn ve do\u011frulu\u011funun US-BI-RADS ve MRI-BI-RADS&#8217;ye k\u0131yasla \u00f6nemli \u00f6l\u00e7\u00fcde daha y\u00fcksek oldu\u011funu bulmu\u015flard\u0131r (p &lt;0.05). Yazarlar, MRI-BI-RADS ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda CEUS-BI-RADS kullan\u0131m\u0131n\u0131n kalsifikasyonlu meme lezyonlar\u0131n\u0131n tan\u0131sal etkinli\u011fini art\u0131rd\u0131\u011f\u0131 sonucuna varm\u0131\u015flard\u0131r.<\/p>\n<p>&nbsp;<\/p>\n<h5><strong><span style=\"color: #3366ff;\">Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer.<\/span> <\/strong><\/h5>\n<p>Samiei, S., Smidt, M. L., Vanwetswinkel, S., Engelen, S. M., Schipper, R., Lobbes, M. B., &amp; Nijnatten, T. J. (2020).<\/p>\n<p>European Radiology, 30(8), 4212-4222.<\/p>\n<p>Link: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32221685\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32221685\/<\/a><\/p>\n<h5><strong>Lenf nodu negatif ve pozitif meme kanserlerinin de\u011ferlendirilmesi i\u00e7in \u00f6zelle\u015ftirilmi\u015f aksiller MRG ile kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda standart meme MRG&#8217;sinin tan\u0131sal performans\u0131.<\/strong><\/h5>\n<p>Bu \u00e7al\u0131\u015fmada, yazarlar meme MRG&#8217;nin tan\u0131sal etkinli\u011fini aksiller b\u00f6lgenin tam g\u00f6r\u00fcnt\u00fcleme alan\u0131 (FOV) ile nod pozitif ve nod negatif meme kanseri vakalar\u0131nda \u00f6zelle\u015ftirilmi\u015f aksiller MRG ile kar\u015f\u0131la\u015ft\u0131rd\u0131. \u00c7al\u0131\u015fmaya, ameliyattan \u00f6nce hem meme MRG \u00a0hem de aksiller MRG uygulanan 47 hasta dahil edildi. Deneyimli meme radyologlar\u0131, her iki MRI incelemesinin kontrasts\u0131z T2 a\u011f\u0131rl\u0131kl\u0131 (T2W) ve dif\u00fczyon a\u011f\u0131rl\u0131kl\u0131 (DW) g\u00f6r\u00fcnt\u00fclerini inceledi. Yazarlar, meme MRG ve aksiller MRG aras\u0131nda tan\u0131sal performans a\u00e7\u0131s\u0131ndan istatistiksel olarak anlaml\u0131 bir fark bulamad\u0131lar. Ayr\u0131ca yazarlar, iyi huylu ve k\u00f6t\u00fc huylu lenf nodlar\u0131n\u0131n hem meme hem de \u00f6zelle\u015ftirilmi\u015f aksiller MRG incelemelerinde DW g\u00f6r\u00fcnt\u00fclemede benzer ADC de\u011ferlerine sahip oldu\u011funu belirlediler. Yazarlar, aksiller b\u00f6lgenin tam FOV&#8217;lu T2W meme MRI&#8217;s\u0131n\u0131n, nod pozitif ve nod negatif hastal\u0131\u011f\u0131 de\u011ferlendirirken T2W&#8217;ye ayr\u0131lm\u0131\u015f aksiller MRI ile kar\u015f\u0131la\u015ft\u0131r\u0131labilir oldu\u011fu sonucuna vard\u0131lar. Ek olarak yazarlar, DW g\u00f6r\u00fcnt\u00fcleme ve ADC de\u011ferlerinin, k\u00f6t\u00fc huylu ve iyi huylu lenf nodlar\u0131n\u0131 ay\u0131rt etmek i\u00e7in klinik olarak \u00f6nemli bilgiler eklemedi\u011fini saptad\u0131lar.<\/p>\n<p>&nbsp;<\/p>\n<h5><strong><span style=\"color: #3366ff;\">Male patients with unilateral breast symptoms: An optimal imaging approach.<\/span> <\/strong><\/h5>\n<p>Yoon, B., Chae, E. Y., Cha, J. H., Shin, H. J., Choi, W. J., &amp; Kim, H. H. (2020).<\/p>\n<p>European Radiology, 30(8), 4242-4250.<\/p>\n<p>Link: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32242274\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32242274\/<\/a><\/p>\n<h5><strong>Unilateral meme semptomlar\u0131 olan erkek hastalar: Optimal g\u00f6r\u00fcnt\u00fcleme planlamas\u0131<\/strong><\/h5>\n<p>Bu ileriye d\u00f6n\u00fck \u00e7al\u0131\u015fmada yazarlar, unilateral meme \u015fikayeti olan erkek hastalarda bilateral mamografinin tan\u0131sal faydas\u0131n\u0131 belirlemeye \u00e7al\u0131\u015ft\u0131lar. \u0130ki y\u00fcz yetmi\u015f bir erke\u011fe bilateral mamografi yap\u0131ld\u0131 ve 1-5 aras\u0131nda modifiye edilmi\u015f BI-RADS skoru verildi. Deneyimli meme radyologlar\u0131 muayenelerin hem unilateral hem de bilateral incelemelerini ger\u00e7ekle\u015ftirdiler. Her iki memenin kontralateral bulgular\u0131 ve ortalama gland\u00fcler dozu kaydedildi. Unilateral meme \u015fikayeti olan erkek hastalar\u0131n% 10.7&#8217;sinde meme kanseri tan\u0131s\u0131 kondu ve bilateral meme kanseri vakas\u0131 yoktu. Yazarlar, tek tarafl\u0131 ve iki tarafl\u0131 incelemelerin tan\u0131sal performans\u0131 aras\u0131nda istatistiksel olarak anlaml\u0131 bir fark bulamad\u0131lar. Yazarlar, tek tarafl\u0131 meme \u015fikayeti olan erkeklerde meme kanseri tan\u0131s\u0131nda unilateral mamografinin bilateral mamografi kadar iyi oldu\u011fu sonucuna varm\u0131\u015flard\u0131r.<\/p>\n<p>&nbsp;<\/p>\n<h5><strong><span style=\"color: #3366ff;\">Muscle mass loss after neoadjuvant chemotherapy in breast cancer: Estimation on breast magnetic resonance imaging using pectoralis muscle area.<\/span> <\/strong><\/h5>\n<p>Rossi, F., Torri, L., Lambertini, M., Giorgis, S. D., Calabrese, M., &amp; Tagliafico, A. S. (2020).<\/p>\n<p>European Radiology, 30(8), 4234-4241.<\/p>\n<p>Link: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32232787\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/32232787\/<\/a><\/p>\n<h5><strong>Meme kanserinde neoadjuvan kemoterapi sonras\u0131 kas k\u00fctlesi kayb\u0131: Pektoralis kas alan\u0131 kullan\u0131larak meme manyetik rezonans g\u00f6r\u00fcnt\u00fclemede tahmin.<\/strong><\/h5>\n<p>Bu \u00e7al\u0131\u015fmada yazarlar, neoadjuvan kemoterapi (NAK) ile tedavi \u00f6ncesi ve sonras\u0131 pektoral kas alan\u0131 (PKA) a\u00e7\u0131s\u0131ndan farkl\u0131l\u0131klar\u0131 ara\u015ft\u0131rmaya \u00e7al\u0131\u015ft\u0131lar. Yazarlar, iskelet kas\u0131 kitlesinde kayb\u0131n meme kanseri hastalar\u0131nda toksisite ve k\u00f6t\u00fc sonu\u00e7lar\u0131n bilinen bir predikt\u00f6r\u00fc oldu\u011fundan, PKA&#8217;daki de\u011fi\u015fiklikleri \u00f6l\u00e7menin klinik olarak \u00f6nemli oldu\u011funu belirtiyorlar. \u00c7al\u0131\u015fmaya NAK \u00f6ncesi ve sonras\u0131 MRG tetkikleri yap\u0131lan 110 hasta dahil edildi. \u0130ki deneyimli meme radyolo\u011fu, her iki muayene i\u00e7in PKA&#8217;y\u0131 hesaplad\u0131. NAK sonras\u0131 PKA de\u011ferleri, NAK \u00f6ncesi de\u011ferlerden anlaml\u0131 derecede d\u00fc\u015f\u00fckt\u00fc (p &lt;0.001). Yazarlar, yan\u0131t vermeyenler ile tam veya k\u0131smi yan\u0131t verenler aras\u0131nda RECIST kriterlerine g\u00f6re istatistiksel olarak anlaml\u0131 bir fark bulamad\u0131. Ek olarak, PKA ile ya\u015f, hormon resept\u00f6r durumu, Ki-67 ekspresyonu, histolojik tip \/ derece veya lenf nodu durumundaki de\u011fi\u015fiklikler aras\u0131nda \u00f6nemli bir ili\u015fki saptanmad\u0131. Yazarlar, NAK ald\u0131ktan sonra meme kanseri hastalar\u0131nda PKA&#8217;n\u0131n \u00f6nemli \u00f6l\u00e7\u00fcde azald\u0131\u011f\u0131 ve MRI&#8217;nin bu \u00f6l\u00e7\u00fcm\u00fc tahmin edebildi\u011fi sonucuna varm\u0131\u015flard\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced [&hellip;]","protected":false},"author":3,"featured_media":3020,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[209],"tags":[],"class_list":["post-8206","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-tr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>What&#039;s new in Breast Imaging (Turkish) - September 2020 - ACORE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What&#039;s new in Breast Imaging (Turkish) - September 2020 - ACORE\" \/>\n<meta property=\"og:description\" content=\"Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"ACORE\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-10T09:20:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Abdelrahman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Abdelrahman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/\",\"url\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/\",\"name\":\"What's new in Breast Imaging (Turkish) - September 2020 - ACORE\",\"isPartOf\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\",\"datePublished\":\"2020-09-10T09:20:26+00:00\",\"author\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#primaryimage\",\"url\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\",\"contentUrl\":\"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg\",\"width\":2560,\"height\":2560,\"caption\":\"Breast Cancer. Female Hands Joined In Circle Holding Pink Ribbons On White Background. View From Above, Shallow Depth\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/staging-hub.acoredu.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What&#8217;s new in Breast Imaging (Turkish) &#8211; September 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#website\",\"url\":\"https:\/\/staging-hub.acoredu.com\/\",\"name\":\"ACORE\",\"description\":\"Radiology education for everyone, everywhere!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging-hub.acoredu.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7\",\"name\":\"Abdelrahman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g\",\"caption\":\"Abdelrahman\"},\"url\":\"https:\/\/staging-hub.acoredu.com\/tr\/author\/abdelrahman\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What's new in Breast Imaging (Turkish) - September 2020 - ACORE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/","og_locale":"tr_TR","og_type":"article","og_title":"What's new in Breast Imaging (Turkish) - September 2020 - ACORE","og_description":"Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced [&hellip;]","og_url":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/","og_site_name":"ACORE","article_published_time":"2020-09-10T09:20:26+00:00","og_image":[{"width":2560,"height":2560,"url":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","type":"image\/jpeg"}],"author":"Abdelrahman","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Abdelrahman","Tahmini okuma s\u00fcresi":"8 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/","url":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/","name":"What's new in Breast Imaging (Turkish) - September 2020 - ACORE","isPartOf":{"@id":"https:\/\/staging-hub.acoredu.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#primaryimage"},"image":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","datePublished":"2020-09-10T09:20:26+00:00","author":{"@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7"},"breadcrumb":{"@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#primaryimage","url":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","contentUrl":"https:\/\/staging-hub.acoredu.com\/wp-content\/uploads\/2020\/07\/female-hands-joined-in-circle-holding-pink-ribbons-RCN683A-scaled.jpg","width":2560,"height":2560,"caption":"Breast Cancer. Female Hands Joined In Circle Holding Pink Ribbons On White Background. View From Above, Shallow Depth"},{"@type":"BreadcrumbList","@id":"https:\/\/staging-hub.acoredu.com\/whats-new-in-breast-imaging-september-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staging-hub.acoredu.com\/"},{"@type":"ListItem","position":2,"name":"What&#8217;s new in Breast Imaging (Turkish) &#8211; September 2020"}]},{"@type":"WebSite","@id":"https:\/\/staging-hub.acoredu.com\/#website","url":"https:\/\/staging-hub.acoredu.com\/","name":"ACORE","description":"Radiology education for everyone, everywhere!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging-hub.acoredu.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/75293c6e4870f3aa293e1394c53df6b7","name":"Abdelrahman","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/staging-hub.acoredu.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2ad7486277da081678ef5e7172d9abecba77465cd62bd4d7272d1141d0b9bca2?s=96&d=mm&r=g","caption":"Abdelrahman"},"url":"https:\/\/staging-hub.acoredu.com\/tr\/author\/abdelrahman\/"}]}},"_links":{"self":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts\/8206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/comments?post=8206"}],"version-history":[{"count":1,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts\/8206\/revisions"}],"predecessor-version":[{"id":8209,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/posts\/8206\/revisions\/8209"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/media\/3020"}],"wp:attachment":[{"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/media?parent=8206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/categories?post=8206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging-hub.acoredu.com\/tr\/wp-json\/wp\/v2\/tags?post=8206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}